Mural Oncology PLC Logo

Mural Oncology PLC

Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.

MURA | BUD

Overview

Corporate Details

ISIN(s):
IE000LK2BOB4
LEI:
Country:
Ireland
Address:
N/A
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Mural Oncology PLC is a clinical-stage oncology company focused on developing novel immunotherapies to treat cancer. The company leverages its proprietary protein engineering platform and expertise in cytokine biology to design and advance a pipeline of cytokine-based therapies. Its mission is to unlock the value of immunotherapy for a broader range of patients, particularly those with cancers that have not responded to previous treatments. The company's lead candidate, nemvaleukin alfa, is a novel, engineered interleukin-2 (IL-2) variant immunotherapy currently in clinical trials for difficult-to-treat solid tumors, including advanced melanoma and platinum-resistant ovarian cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-24 22:25
Post-Annual General Meeting Information
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisiti…
English 31.3 KB
2025-09-24 01:52
Proxy Solicitation & Information Statement
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement …
English 18.3 KB

Automate Your Workflow. Get a real-time feed of all Mural Oncology PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mural Oncology PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mural Oncology PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

SBI Leasing Services Co.,Ltd. Logo
Structures Japanese Operating Leases for aircraft & ships for corporate investors.
Japan
5834
Schrodinger, Inc. Logo
A physics-based computational platform for accelerated drug and materials discovery.
United States of America
SDGR
Sensorion Logo
Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.
France
ALSEN
SERENDIP HOLDINGS Co.,Ltd. Logo
Consulting & investment firm aiding manufacturing SMEs with M&A, succession, and revitalization.
Japan
7318
SEYFERT LTD. Logo
Provides recruitment, staffing, and education services for the beauty salon industry.
Japan
9213
SG Company Logo
A consulting firm for 360° communication, marketing, and event services for businesses.
Italy
SGC
SHIKIGAKU.Co.,Ltd. Logo
Drives organizational growth with a unique management theory for diverse corporate clients.
Japan
7049
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. Logo
A contract research organization providing preclinical and clinical services for medical industries.
Japan
2395
A healthcare support company for medical facilities, offering consulting, equipment, and supplies.
Japan
3360
Silence Therapeutics plc Logo
Develops RNAi therapies that silence disease genes for rare and underserved conditions.
United States of America
SLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.